RANDAL J KIRK Insider Trading $APHB Armata Pharmaceuticals, Inc.
Get free email notifications about insider trading for RANDAL J KIRK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).
RANDAL J KIRK in Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RANDAL J KIRK: 10% Owner
Holdings: 802,263 shares
Current Value: $433,222
Latest Transaction: Dec 29 2016
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RANDAL J KIRK in Armata Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.45 | 20,077 | 9,035 | 674,169 | 694.2 K to 674.2 K (-2.89 %) |
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.47 | 40,450 | 19,012 | 694,246 | 734.7 K to 694.2 K (-5.51 %) |
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.51 | 24,092 | 12,287 | 734,696 | 758.8 K to 734.7 K (-3.18 %) |
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.45 | 21,923 | 9,865 | 736,170 | 758.1 K to 736.2 K (-2.89 %) |
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.47 | 44,170 | 20,760 | 758,093 | 802.3 K to 758.1 K (-5.51 %) |
| Dec 29 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Sell | S | 0.51 | 26,308 | 13,417 | 802,263 | 828.6 K to 802.3 K (-3.18 %) |
| Nov 16 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Option Exercise | C | 0.00 | 2,142,857 | 0 | 0 | |
| Nov 16 2016 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Buy | C | 0.00 | 428,571 | 0 | 828,571 | 400 K to 828.6 K (+107.14 %) |
| Mar 18 2015 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Option Exercise | P | 0.22 | 3,484,848 | 749,242 | 3,484,848 | |
| Mar 18 2015 | APHB | AmpliPhi Bioscienc ... | KIRK RANDAL J | 10% Owner | Buy | P | 0.17 | 13,939,392 | 2,300,000 | 37,939,392 | 24 M to 37.9 M (+58.08 %) |
Page: 1